GENE ONLINE|News &
Opinion
Blog

2018-11-22| PartnerAsia-Pacific

Med X Tech Summit Asia (MEDTEX) 2018 – Overview of Day 1 Program

by Rajaneesh K. Gopinath
Share To

By Rajaneesh K. Gopinath, Ph.D.

Proudly co-organized by GeneOnline, the global biotech conference brings key opinion leaders comprising healthcare professionals and technology giants under one roof promoting scientific exchange and business partnerships. The event is to be held from Nov 29 – 30, 2018 at the Grande Luxe Banquet, Taipei, Taiwan.

This year, Taipei will bag the honor of hosting MEDTEX 2018, a showcase event displaying the digital revolution in the healthcare industry. This event is as an ideal opportunity to witness the latest advances in next generation bio-therapeutics and breakthroughs in precision medicine. MEDTEX will serve as the focal point where cutting-edge research and technology meet business perspectives. Expert talks will be delivered on various hot topics encompassing AIoT, Immune-Oncology, Blockchain, Big data, Gene editing and Cell therapy among others.

The following are some of the major highlights on the first day of the conference.

The guests will be welcomed with opening remarks from two honorary figures, Mr. Jia-Chyuan Su, President, Legislative Yuan (R.O.C) and Dr. Chi-Huey Wong, Distinguished Research Fellow at Academia Sinica.

1) The global healthcare industry is constantly evolving with the advent of new technologies and collaborative participation of many international players. Therefore, the inaugural program of the session is titled CEO Perspectives where a panel of distinguished speakers from various premier industries would discuss on the topic “Foreseeing the Future of Healthcare – Cross-industry Opportunities and Challenges of Healthcare Advances”. The goal is to garner key insights on cross-industry cooperation opportunities, challenges and strategies. The discussion will be moderated by Simon Chang, the Chairman of IBMI. The key members of the panel include Murakami Sei (Hitachi), Birgit Reitmaier (Merck), Larry Merizalde (Teva), Eunice Chiu (NVIDIA) and Harry Yang (Qisda).

2) The second panel discussion would focus on the new breakthroughs in the rapidly advancing fields of Immuno-oncology, Next generation Biotherapeutics and Gene editing. The discussion will be moderated by Clifford Chao, Vice President of the China Medical University. The speakers in the panel include Seigo Izumo (Takeda Pharma), Wise Young (StemCyte), David DiGiusto (Semma Therapeutics) and Tony J.C. Wang, (Columbia University Medical Center). The discussion also includes fireside chats from Trevor Martin (Mammoth Biosciences) and Chris Shu (Pacific 8 Ventures).

3) The final discussion session on the first day is titled Delivering Personalized Healthcare through Precision Medicine. The discussion will be moderated by Yun Yen, the Chair Professor of Taipei Medical University. The speakers in the panel include Alireza Haghighi (Harvard Medical School), Colin Collins (Vancouver Prostate Centre) and Liang-Yeu Lenny Chen (IBM Watson Health).

Interesting talks and discussions are also scheduled for the second day of the event. Follow GeneOnline for more details.

To register for the event, please visit

https://www.eventbrite.com/e/medtex-med-x-tech-summit-asia-2018-tickets-50897919046

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
The Gates Foundation Boosts Global Health Innovations with Record $8.6 Billion Budget
2024-01-18
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
LATEST
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
Degrader-Antibody Conjugates (DACs): Targeted Degradation for Therapeutics
2024-02-19
EVENT
Scroll to Top